Pfizer Giving You A Raise

12/21/17

By Josh Arnold, SeekingAlpha

Image credit

Pfizer (PFE) has long been a strong dividend stock. The big pharma area is littered with companies that pay nice yields. But PFE has made its name with investors by paying a large, well-covered dividend for many years. Like other big pharmas, PFE always is on the prowl for its next acquisition. But to its credit, it has used excess cash consistently to return to shareholders by a billion each year. And with its newly-announced dividend increase, it is once again reaffirming its commitment to those who hold its stock. In this article, using data from Seeking Alpha and charts I’ve created, I’ll take a look at PFE’s new dividend obligation in light of its FCF production as well as the raised buyback authorization.

READ FULL ARTICLE HERE